32
https://pubmed.ncbi.nlm.nih.gov/38114366
The PreciseDx digital breast cancer test for predicting early-stage recurrence shows robustness and reproducibility in its analytical validation.
“Analytical Validation of PreciseDx Digital Breast Cancer Test Shows Robustness and Reproducibility in Predicting Early-Stage Recurrence”
